0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Special Feature |

Pathological Case of the Month FREE

[+] Author Affiliations

Section Editor: Enid Gilbert-barness, MD

More Author Information
Arch Pediatr Adolesc Med. 2001;155(6):736. doi:10.1001/archpedi.155.6.735.
Text Size: A A A
Published online

DIAGNOSIS AND DISCUSSION: AMELOBLASTIC FIBROMA OF THE MAXILLA

Figure 1. Expansile mass in the left maxilla, loss of the lateral wall of the maxilla, and extension of the mass into the palatine bone. Most of the developing teeth on the left side are not depicted.

Figure 2. Grayish, loose, friable tissue extending from the anterior to the left maxillary tuberosity area.

Figure 3. Islands of odontogenic epithelium in cellular mesenchymal stroma (hematoxylin-eosin, original magnification ×40).

Figure 4. Peripheral columnar cells and central loosely arranged epithelial cells in islands of odontogenic epithelium. Cellular mesenchyme resembles developing dental papilla (hematoxylin-eosin, original magnification ×200).

Histopathologically, the excised neoplasm was composed of islands of odontogenic epithelium, resembling developing enamel organ with peripheral columnar cells and central loosely arranged epithelial cells, and cellular mesenchymal tissue with stellate and spindle-shaped cells resembling developing dental papilla. The mitotic count was low.

Ameloblastic fibroma (AF) is a benign tumor of odontogenic origin. It is composed of proliferative odontogenic epithelium and mesenchymal tissue resembling primitive dental papilla. Comprising approximately 2.5% of odontogenic tumors, AF was first described by Kruse et al1 in 1891. It is more common in children than adults; the average age of onset is 15 years (range, 7 weeks to 42 years).13 There is no apparent predilection for race or sex.2,4 The most common clinical presentation is painless facial swelling, although delayed tooth eruption and gingival cysts have been reported as well.46 Radiographically, the lesion appears as unilocular or multilocular radiolucencies. Expansion of the cortex is occasionally seen, and involvement with unerupted teeth is common. The lesions are primarily intraosseous ranging in size from 0.5 to 8.5 cm with 80% to 90% of lesions occurring in the mandible.1,4 The clinical differential diagnosis, which requires histopathologic studies, includes neuroectodermal tumor of infancy, ameloblastoma, odontogenic or developmental cyst, ameloblastic fibrosarcoma, and osteogenic sarcoma.

The need for precise histologic diagnosis of AF is uniformly agreed on throughout the literature.68 It is histologically similar to 2 other tumors of odontogenic origin: the ameloblastoma and the ameloblastic fibrosarcoma. As of July 1990, Girdler and Edwards2 found only 98 reported cases of AF in the English-language literature. In 1998, Mosby et al1 found only 4 reports of anterior maxillary AF, and they subsequently reported a fifth. Although AF is considered benign, there is still debate over how aggressive one should be in its removal because AF has an 18.3% incidence of recurrence (14 of 82 cases) when treated with simple enucleation and curettage alone.1 Also, it has been found that 44% of the time, ameloblastic fibrosarcoma develops its origins within AF.9 Given the rarity of these tumors, there is limited data regarding the outcome of various surgical approaches. Some have recommended wide local excision as the initial approach,9 while others have concluded that this results in serious disfigurement with unproven long-term benefit.1 In this case, aggressive curettage instead of block resection was performed mainly because of the close proximity of the posterior margin of the tumor to the base of the skull.

Long-term, possibly lifelong, monitoring to detect any recurrence of the tumor will be required for this patient, including clinical and radiographic follow-up every 6 months. Ultimately, bone grafting of the maxillary deformity will be carried out in sequential steps, depending on the growth outcome of the facial bones. The missing teeth will be replaced with implants. Additional surgical intervention in the case of tumor recurrence would include curettage or block resection. Ameloblastic fibroma is not responsive to radiation or chemotherapy. This case constitutes the sixth reported case to our knowledge.

Accepted for publication September 15, 1999.

We thank John R. Kalmar, DMD, PhD, for his assistance in the histopathologic diagnosis.

Reprints: Paul F. Lehoullier, MD, PhD, Rochester General Pediatric Associates, Rochester General Hospital, 1425 Portland Ave, Rochester, NY 14621.

Mosby  ELRussell  DNoren  SBarker  BF Ameloblastic fibroma in a 7-week-old infant: a case report and review of the literature. J Oral Maxillofac Surg. 1998;56368- 372
Link to Article
Girdler  NMEdwards  DM Ameloblastic fibroma: an unusual case of facial swelling in a young child. Br Dent J. 1990;16957- 58
Link to Article
Sapp  JP Intraosseous lesions of the maxilla and mandible. Sanders  Bed.Pediatric Oral and Maxillofacial Surgery St Louis, Mo CV Mosby Co1979;307- 308
Meyers  APoulson  TPettigrew  JClark  M Cystic ameloblastic fibroma. Ear Nose Throat J. 1991;70729- 732
Kusama  KMiyake  MMoro  I Peripheral ameloblastic fibroma of the mandible: report of a case. J Oral Maxillofac Surg. 1998;56399- 401
Link to Article
Baroni  CFarneti  MStea  SRimondini  L Ameloblastic fibroma and impacted mandibular first molar. Oral Surg Oral Med Oral Pathol. 1992;73548- 549
Link to Article
Carrillo  RCuesta  CRodriguez-Peralto  JLMatin  J Ameloblastic fibroma: report of a case with fine needle aspiration cytologic findings. Acta Cytol. 1992;36537- 540
Nogueira  TOCarvalho  YRRosa  LEBSantos  LM Possible malignant transformation of an ameloblastic fibroma to ameloblastic fibrosarcoma: a case report. J Oral Maxillofac Surg. 1997;55180- 182
Link to Article
Muller  SParker  DCKapadia  SB  et al.  Ameloblastic fibrosarcoma of the jaws: a clinicopathologic and dna analysis of five cases and review of the literature with discussion of its relationship to ameloblastic fibroma. Oral Surg Oral Med Oral Pathol. 1995;79467- 477
Link to Article

Tables

References

Mosby  ELRussell  DNoren  SBarker  BF Ameloblastic fibroma in a 7-week-old infant: a case report and review of the literature. J Oral Maxillofac Surg. 1998;56368- 372
Link to Article
Girdler  NMEdwards  DM Ameloblastic fibroma: an unusual case of facial swelling in a young child. Br Dent J. 1990;16957- 58
Link to Article
Sapp  JP Intraosseous lesions of the maxilla and mandible. Sanders  Bed.Pediatric Oral and Maxillofacial Surgery St Louis, Mo CV Mosby Co1979;307- 308
Meyers  APoulson  TPettigrew  JClark  M Cystic ameloblastic fibroma. Ear Nose Throat J. 1991;70729- 732
Kusama  KMiyake  MMoro  I Peripheral ameloblastic fibroma of the mandible: report of a case. J Oral Maxillofac Surg. 1998;56399- 401
Link to Article
Baroni  CFarneti  MStea  SRimondini  L Ameloblastic fibroma and impacted mandibular first molar. Oral Surg Oral Med Oral Pathol. 1992;73548- 549
Link to Article
Carrillo  RCuesta  CRodriguez-Peralto  JLMatin  J Ameloblastic fibroma: report of a case with fine needle aspiration cytologic findings. Acta Cytol. 1992;36537- 540
Nogueira  TOCarvalho  YRRosa  LEBSantos  LM Possible malignant transformation of an ameloblastic fibroma to ameloblastic fibrosarcoma: a case report. J Oral Maxillofac Surg. 1997;55180- 182
Link to Article
Muller  SParker  DCKapadia  SB  et al.  Ameloblastic fibrosarcoma of the jaws: a clinicopathologic and dna analysis of five cases and review of the literature with discussion of its relationship to ameloblastic fibroma. Oral Surg Oral Med Oral Pathol. 1995;79467- 477
Link to Article

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles